Compound Overview

What Is Glutathione?

An endogenous tripeptide built from glutamate, cysteine and glycine — the cell's principal small-molecule antioxidant and one of the most-studied players in redox balance, detoxification and mitochondrial protection.

AntioxidantTripeptide (Glu-Cys-Gly)Redox / GSH-GSSG

Overview

Glutathione (often abbreviated GSH) is a tripeptide assembled from L-glutamate, L-cysteine and glycine. Unlike most peptides, its glutamate residue connects through an unusual gamma-carboxyl linkage rather than the standard alpha-peptide bond, which makes the molecule resistant to ordinary peptidases. It is synthesized inside virtually every cell and reaches millimolar concentrations in the cytosol, making it the dominant non-protein thiol in the body. Across the research literature it is treated as a central reference point for studying oxidative stress, because the ratio of its reduced form (GSH) to its oxidized disulfide form (GSSG) is a widely used readout of a cell's redox state.

How Glutathione Works

The reactive heart of the molecule is the free thiol (-SH) group on its cysteine residue. That thiol donates electrons to neutralize reactive oxygen species and other electrophiles; in doing so two glutathione molecules couple into the oxidized disulfide GSSG. The enzyme glutathione reductase, drawing reducing power from NADPH, then regenerates the reduced pool, so the system operates as a continuously recycled redox buffer rather than a one-shot scavenger. Glutathione also serves as the substrate for glutathione peroxidases, which detoxify hydrogen peroxide and lipid peroxides, and for glutathione S-transferases, which conjugate it onto xenobiotics and toxins to flag them for export. Within mitochondria a dedicated glutathione pool helps shield the electron-transport chain from the oxidative byproducts of respiration.

What the Research Explores

  • Cellular redox homeostasis and the GSH:GSSG ratio as a marker of oxidative stress.
  • Phase II detoxification and conjugation of electrophiles, drugs and toxins.
  • Mitochondrial protection and the maintenance of respiratory-chain integrity.
  • Cysteine availability as the rate-limiting input to glutathione biosynthesis.
  • Crosstalk with other antioxidant systems such as vitamins C and E and the NADPH supply.

Forms & Handling

For laboratory work glutathione is usually supplied as a lyophilized powder, with the reduced form (GSH) and the oxidized form (GSSG) sold separately because they behave very differently in assays. A representative research vial holds 1500 mg and is reconstituted with sterile or bacteriostatic water; see the dosing protocol below for the concentration math expressed in syringe units. The reduced thiol is readily air-oxidized once dissolved, so solutions are typically prepared fresh, protected from light, kept cold and used promptly. Powder is stored cool and dry, and many protocols call for freezing aliquots to limit repeated freeze-thaw cycles.

Safety & Research Notes

Glutathione discussed here is handled as an investigational research compound. While it is a naturally occurring molecule, the material referenced on this page is intended for in-vitro and laboratory study, with no approved human or veterinary administration protocol and no established dosing safety profile in that context. Everything described above is mechanistic and biochemical background, not a usage recommendation.

Research-use note. Glutathione is supplied strictly for in-vitro and laboratory research. It is not approved for human or veterinary use, and nothing on this page constitutes medical advice or dosing instruction.

References

  1. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine (2009). pmc.ncbi.nlm.nih.gov/articles/PMC2696075
  2. Wu G, Fang YZ, Yang S, et al. Glutathione metabolism and its implications for health. Journal of Nutrition (2004). pubmed.ncbi.nlm.nih.gov/14988435
  3. Ribas V, García-Ruiz C, Fernández-Checa JC. Glutathione and mitochondria. Frontiers in Pharmacology (2014). pmc.ncbi.nlm.nih.gov/articles/PMC4076647

Related Protocols